(3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate, CAS [[115375-60-5]]

Produktübersicht

• Artikelname: (3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate, CAS [[115375-60-5]]
• Artikelnummer: MCE-HY-75624
• Hersteller Artikelnummer: HY-75624
• Alternativnummer: MCE-HY-75624-50MG, MCE-HY-75624-1G, MCE-HY-75624-500MG, MCE-HY-75624-250MG, MCE-HY-75624-100MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: (3beta)-17-{[(Trifluoromethyl)sulfonyl]oxy}androsta-5,16-dien-3-yl acetate

Produktbeschreibung

(3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate ((3beta)-17-{[(Trifluoromethyl)sulfonyl]oxy}androsta-5,16-dien-3-yl acetate) is a drug intermediate for synthesis of various active compounds.

Produkteigenschaften

• Molekulargewicht: 462.52
• Reinheit: 99.16
• CAS Nummer: [115375-60-5]
• Formel: C22H29F3O5S
• Target-Kategorie: Drug Intermediate

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound